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As noted in the preface to this book - which is not the usual 
collection of papers from a conference but a studied attempt 
by the editors to put together a reasonably up-to-date, com- 
prehensive set of reviews from five of the top oncogene 
research groups - over the past ten years there has been ‘an ex- 
plosion in our knowledge of cellular genes which function ab- 
normally during oncogenic transformation’. What is not men- 
tioned, however, is that the honeymoon is over and discarding 
the rose-tinted glasses of enthusiastic discovery, we see that we 
have upwards of fifty new oncogene babies to play with. 
The simultaneous advent of retroviral and gene cloning 
technologies enabled this great step forward. But it is becom- 
ing evident that more breakthroughs will be required to find 
out exactly how even a single member of this prodigous family 
exerts its effect. The reader of this edition will soon see that 
all authors descend into a labyrinth of experimental results 
from around the world none of which lead to a satisfactory 
conclusion. Speculation is to be had in plenty but it is a 
dangerous pastime since many of the obvious deductions, for 
example, that rus gene products are G-proteins stuck in the ac- 
tivation mode or that the erb and fms products are truncated 
growth factor receptors that permanently stimulate cell 
division-mediating second messenger systems, have not 
received by any stretch of the eye of faith unequivocal ex- 
perimental support. 
Oncologists are now in fact facing the problem that has 
beset biochemists and cell biologists from time immemorial: 
how to study complicated interwoven chemical reaction 
pathways inside the cell. There is still no direct way and the in- 
vestigation of oncogene function is now wallowing in the 
sticky mire of dubious and untestable inferences from indirect 
approaches, a situation very reminiscent of the mammalian 
gene expression field during the seventies before the advent of 
specific gene probes. It may be a considerable number of years 
before the first oncogene action path is worked out to the 
satisfaction of all experimentalists. 
In the meantime, collected reviews such as this are especial- 
ly useful to those who need to keep abreast of current ex- 
perimental details in the now vast literature. For such, this 
paperback will be a valuable addition to the bookshelf - until 
the next ones comes out. 
One further comment: despite the fact that oncogene 
research is revealing much fascinating information about the 
mammalian cell’s molecular machinery, there are those who 
wonder faintly whether any information of direct use to the 
cancer patient will ever be generated. In this regard it was 
heartening to be told in Marshall’s imaginative chapter that at 
least eight oncogenes have now been definitely implicated in 
human cancer. 
C. J. Chesterton 
Ubiquitin; Edited by Martin Rechsteiner; Plenum Press; New York and London, 1988, 346 pages; 59.50. 
Ubiquitin is a small polypeptide of 76 amino acid residues. 
The name reflects the fact that ubiquitin is the most highly 
conserved protein known and can be found in all eukaryotic 
cells examined but not in prokaryotes, despite early claims to 
the contrary. Since its discovery in 1975 research has shown 
that ubiquitin may be found in the nucleus, cytoplasm and cell 
surface which demonstrates further the molecule’s ubiquity. 
In his introduction to this book devoted to just one of the 
many thousand different polypeptides which cells can pro- 
duce, the editor, Martin Rechsteiner, suggests that ubiquitin 
is a lucky molecule because many who have taken it upon 
themselves to study it have made unexpected and fascinating 
observations and these are clearly reflected in this volume. 
The chapters range from descriptions of ubiquitin’s purifica- 
tion and characterization including crystal structure, its 
genetics and metabolism, the possible roles in chromatin, lym- 
phocyte receptors and as a molecular marker for protein 
degradation. With the exception of the inclusion of a chapter 
devoted mostly to protein turnover in Escherichia coli, which 
does not synthesize ubiquitin, there is little to criticise. The 
chapters are stimulating and thought-provoking to read. As 
may be expected, a large proportion of the book is devoted to 
the role which ubiquitin plays in intracellular protein 
catabolism. There are chapters covering ubiquitin activation 
and ligation to potential substrates, the hydrolases and 
isopeptidases which de-ubiquitinate the conjugates, the in- 
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